Cargando…

Opioid substitution therapy in manipur and nagaland, north-east india: operational research in action

BACKGROUND: There is good evidence for the effectiveness of opioid substitution therapy (OST) for injecting drug users (IDUs) in middle and high-income countries but little evidence regarding the provision of OST by non-government organisations (NGOs) in resource-poor settings. This paper reports on...

Descripción completa

Detalles Bibliográficos
Autores principales: Armstrong, Gregory, Kermode, Michelle, Sharma, Charan, Langkham, Biangtung, Crofts, Nick
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3003202/
https://www.ncbi.nlm.nih.gov/pubmed/21122129
http://dx.doi.org/10.1186/1477-7517-7-29
_version_ 1782193835135205376
author Armstrong, Gregory
Kermode, Michelle
Sharma, Charan
Langkham, Biangtung
Crofts, Nick
author_facet Armstrong, Gregory
Kermode, Michelle
Sharma, Charan
Langkham, Biangtung
Crofts, Nick
author_sort Armstrong, Gregory
collection PubMed
description BACKGROUND: There is good evidence for the effectiveness of opioid substitution therapy (OST) for injecting drug users (IDUs) in middle and high-income countries but little evidence regarding the provision of OST by non-government organisations (NGOs) in resource-poor settings. This paper reports on outcomes of an NGO-based OST program providing sub-lingual buprenorphine to opiate dependent IDUs in two north-east Indian states (Manipur and Nagaland), a region where conflict, under-development and injecting of heroin and Spasmoproxyvon (SP) are ongoing problems. The objectives of the study were: 1) to calculate OST treatment retention, 2) to assess the impact on HIV risk behaviours and quality of life, and 3) to identify client characteristics associated with cessation of treatment due to relapse. METHODS: This study involves analysis of data that were routinely and prospectively collected from all clients enrolled in an OST program in Manipur and Nagaland between May 2006 and December 2007 (n = 2569, 1853 in Manipur and 716 in Nagaland) using standardised questionnaires, and is best classified as operational research. The data were recorded at intake into the program, after three months, and at cessation. Outcome measures included HIV risk behaviours and quality of life indicators. Predictors of relapse were modelled using binary logistic regression. RESULTS: Of all clients enrolled in OST during the month of May 2006 (n = 713), 72.8% remained on treatment after three months, and 63.3% after six months. Statistically significant (p = 0.05) improvements were observed in relation to needle sharing, unsafe sex, incidents of detention, and a range of quality of life measures. Greater spending on drugs at intake (OR 1.20), frequently missing doses (OR 8.82), and having heroin rather than SP as the most problematic drug (OR 1.95) were factors that increased the likelihood of relapse, and longer duration in treatment (OR 0.76) and regular family involvement in treatment (OR 0.20) reduced the likelihood of relapse. CONCLUSION: The findings from this operational research indicate that the provision of OST by NGOs in the severely constrained context of Manipur and Nagaland achieved outcomes that are internationally comparable, and highlights strategies for strengthening similar programs in this and other resource-poor settings.
format Text
id pubmed-3003202
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30032022010-12-18 Opioid substitution therapy in manipur and nagaland, north-east india: operational research in action Armstrong, Gregory Kermode, Michelle Sharma, Charan Langkham, Biangtung Crofts, Nick Harm Reduct J Research BACKGROUND: There is good evidence for the effectiveness of opioid substitution therapy (OST) for injecting drug users (IDUs) in middle and high-income countries but little evidence regarding the provision of OST by non-government organisations (NGOs) in resource-poor settings. This paper reports on outcomes of an NGO-based OST program providing sub-lingual buprenorphine to opiate dependent IDUs in two north-east Indian states (Manipur and Nagaland), a region where conflict, under-development and injecting of heroin and Spasmoproxyvon (SP) are ongoing problems. The objectives of the study were: 1) to calculate OST treatment retention, 2) to assess the impact on HIV risk behaviours and quality of life, and 3) to identify client characteristics associated with cessation of treatment due to relapse. METHODS: This study involves analysis of data that were routinely and prospectively collected from all clients enrolled in an OST program in Manipur and Nagaland between May 2006 and December 2007 (n = 2569, 1853 in Manipur and 716 in Nagaland) using standardised questionnaires, and is best classified as operational research. The data were recorded at intake into the program, after three months, and at cessation. Outcome measures included HIV risk behaviours and quality of life indicators. Predictors of relapse were modelled using binary logistic regression. RESULTS: Of all clients enrolled in OST during the month of May 2006 (n = 713), 72.8% remained on treatment after three months, and 63.3% after six months. Statistically significant (p = 0.05) improvements were observed in relation to needle sharing, unsafe sex, incidents of detention, and a range of quality of life measures. Greater spending on drugs at intake (OR 1.20), frequently missing doses (OR 8.82), and having heroin rather than SP as the most problematic drug (OR 1.95) were factors that increased the likelihood of relapse, and longer duration in treatment (OR 0.76) and regular family involvement in treatment (OR 0.20) reduced the likelihood of relapse. CONCLUSION: The findings from this operational research indicate that the provision of OST by NGOs in the severely constrained context of Manipur and Nagaland achieved outcomes that are internationally comparable, and highlights strategies for strengthening similar programs in this and other resource-poor settings. BioMed Central 2010-12-01 /pmc/articles/PMC3003202/ /pubmed/21122129 http://dx.doi.org/10.1186/1477-7517-7-29 Text en Copyright ©2010 Armstrong et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<url>http://creativecommons.org/licenses/by/2.0</url>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Armstrong, Gregory
Kermode, Michelle
Sharma, Charan
Langkham, Biangtung
Crofts, Nick
Opioid substitution therapy in manipur and nagaland, north-east india: operational research in action
title Opioid substitution therapy in manipur and nagaland, north-east india: operational research in action
title_full Opioid substitution therapy in manipur and nagaland, north-east india: operational research in action
title_fullStr Opioid substitution therapy in manipur and nagaland, north-east india: operational research in action
title_full_unstemmed Opioid substitution therapy in manipur and nagaland, north-east india: operational research in action
title_short Opioid substitution therapy in manipur and nagaland, north-east india: operational research in action
title_sort opioid substitution therapy in manipur and nagaland, north-east india: operational research in action
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3003202/
https://www.ncbi.nlm.nih.gov/pubmed/21122129
http://dx.doi.org/10.1186/1477-7517-7-29
work_keys_str_mv AT armstronggregory opioidsubstitutiontherapyinmanipurandnagalandnortheastindiaoperationalresearchinaction
AT kermodemichelle opioidsubstitutiontherapyinmanipurandnagalandnortheastindiaoperationalresearchinaction
AT sharmacharan opioidsubstitutiontherapyinmanipurandnagalandnortheastindiaoperationalresearchinaction
AT langkhambiangtung opioidsubstitutiontherapyinmanipurandnagalandnortheastindiaoperationalresearchinaction
AT croftsnick opioidsubstitutiontherapyinmanipurandnagalandnortheastindiaoperationalresearchinaction